Clinical Trials

Click Therapeutics, Inc., develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. Click conducts studies to evaluate these mobile applications in the treatment of disease.

The Clinical Trial Journey

What is a Clinical Trial?

Clinical trials are carefully designed research studies that evaluate safety, efficacy and effectiveness of new treatments or interventions. The process involves screening for eligibility, providing informed consent, actively participating in the study, and undergoing monitoring by experienced healthcare professionals.

Be Represented

Click invites participants from a variety of backgrounds to see if they are eligible for a Click-sponsored clinical trial. By participating in our clinical trials, you can help us to advance medical knowledge, improve health outcomes, and improve health equity for all.

Advance Science

Your participation and feedback in our studies may help the development of our Study Apps, which, in the future, may benefit you and/or others impacted by a disease.

What do Click Therapeutic Clinical Trials Look Like?

Our studies are for research purposes only, and your participation is voluntary. Our Click-sponsored clinical trials may involve the items below.

01 Pre-screening

Our pre-screening questionnaires help us to better understand if the study you may be interested in is right for you.

02 Consent Process and Screening

If you are eligible, you will be asked for your consent to take part in a clinical research study. This document, called a consent form, provides a summary of the research so you can decide whether or not to take part. Before choosing to be part of one of our studies, you must read the consent form to understand what you will be asked to do. You may ask the study staff any questions you have regarding the information the form contains. If you decide to participate in our research and sign a study consent form, the study staff can begin the screening process to see if you qualify to be in the study.

03 Participate in the Study

Each experimental intervention we develop is fully accessible through your personal mobile device. You will be asked to complete any trial activities as specified in the consent form and you will be compensated for your time. The trial is actively monitored by experienced healthcare professionals to ensure that your safety as a participant is prioritized and the data collected reflects your real-world experience in the trial.

Privacy Statement

Patient privacy and safety is our top priority. We follow all applicable regulations and laws pertaining to clinical trials and personal data. For more information please see Click’s Privacy Policy.

Diversity Statement

At Click Therapeutics we are committed to conducting inclusive clinical trials. We believe that diverse representation in research is essential to advancing medical knowledge and improving healthcare outcomes for all. Click encourages participants from diverse backgrounds to see if our trial opportunities are a good fit for you. See a list of our trial opportunities below.

Our Current Trials

Virtual migraine study for the prevention of episodic migraine in adults and late adolescents

Enrolling

Learn More

The purpose of this study is to evaluate two investigational mobile-based software applications (apps), known as digital therapeutics, as an add-on to your existing migraine treatment plan. The digital therapeutics are being studied as possible treatments that could reduce the number of migraines you experience.

Virtual migraine study for the prevention of episodic migraine in adults and late adolescents receiving CGRP therapy

Enrolling

Learn More

Virtual migraine study for the prevention of episodic migraine in adults and late adolescents receiving CGRP therapy

Virtual study evaluating the effects of a digital intervention on attentional biases and cognition in Multiple Sclerosis, Breast Cancer, and Lung Cancer

Enrolling

Learn More

The purpose of the study is to evaluate the initial effects of two mobile applications, with an intent to understand whether or not they can change things like symptoms of fatigue, cognition, or pain.

A study evaluating potential treatments for late adolescents and adults who experience negative schizophrenia symptoms with things like their motivation or ability to enjoy life

Enrolling

Learn More

This study is researching two different mobile apps to see if they are safe and effective in helping people who have certain symptoms of schizophrenia. This study will see which app can be part of a schizophrenia treatment plan.

A study evaluating the potential treatment effects of an abbreviated digital therapeutic in late adolescents and adults who are diagnosed with schizophrenia

Enrolling

The purpose of this research project is to learn more about how people with schizophrenia interact with an investigational mobile application built by the Sponsor. The mobile application is a part of a digital therapeutic being built which is designed to help people experiencing certain types of symptoms of schizophrenia.

Virtual study evaluating the effects of a digital intervention on disrupting scratching in Atopic Dermatitis and Psoriasis

Inactive

The purpose of the study is to evaluate the initial effects of two mobile applications, with an intent to understand whether or not they can change things like scratching behavior.

Upcoming Trials

We are looking for curious individuals to help drive development of novel prescription digital therapeutics. If none of the above study opportunities look like a fit for you, please provide your information below and we will contact you for future study opportunities.

Completed Trials

A study evaluating how adults and late adolescents with negative symptoms of schizophrenia interact with an investigational mobile application

Inactive

The purpose of this research study is to learn more about how people with schizophrenia interact with an investigational mobile application built by the Sponsor. The mobile application is a part of a digital therapeutic being built which is designed to help people experiencing negative symptoms of schizophrenia.